Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva plus Gemcitabine in Advanced Pancreatic Cancer
NCT00026338Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Oct 2001
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of erlotinib in pancreatic cancer (PC), sponsored by Canadian Cancer Trials Group. Started Oct 2001; status: completed.
02
Drugs
erlotinib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00026338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026338.